|
5KSU
Crystal structure of HLA-DQ2.5-CLIP1 at 2.73 resolution
Deposited 2016-07-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–198(198 aa)
Fragment:UNP residues 1-198
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;PEG 8000, ammonium sulphate, sodium cacodylate, glycerol
|
Resolution 2.73 Å
R-free 0.249
|
|
5KSU
Crystal structure of HLA-DQ2.5-CLIP1 at 2.73 resolution
Deposited 2016-07-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–198(198 aa)
Fragment:UNP residues 1-198
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;PEG 8000, ammonium sulphate, sodium cacodylate, glycerol
|
Resolution 2.73 Å
R-free 0.249
|
|
5KSV
Crystal structure of HLA-DQ2.5-CLIP2
Deposited 2016-07-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–198(198 aa)
Fragment:UNP residues 1-198
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;291 K;0.1 M BIS-TRIS, pH 5.5, 22% PEG 3350
|
Resolution 2.19 Å
R-free 0.210
|
|
6MFF
HLA-DQ2-glia-omega1
Deposited 2018-09-10
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;23% PEG3350 and 0.1 M NaH2PO4, pH 6
|
Resolution 2.60 Å
R-free 0.250
|
|
6MFG
HLA-DQ2-glia-alpha1
Deposited 2018-09-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain E
1–192(192 aa)
Chain F
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;23% PEG3350 and 0.1 M NaH2PO4, pH 6
|
Resolution 2.00 Å
R-free 0.222
|
|
6U3M
DQ2-P.fluor-alpha1a
Deposited 2019-08-22
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–192(192 aa)
|
Not recorded
|
GOL GLYCEROL × 2
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;18% PEG3350 and 0.15M NH4H2PO4
|
Resolution 1.90 Å
R-free 0.220
|
|
6U3M
DQ2-P.fluor-alpha1a
Deposited 2019-08-22
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–192(192 aa)
|
Not recorded
|
GOL GLYCEROL × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;18% PEG3350 and 0.15M NH4H2PO4
|
Resolution 1.90 Å
R-free 0.220
|
|
6U3N
LS2.8/3.15 - DQ2-P.fluor-alpha1a complex
Deposited 2019-08-22
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;22% PEG3350, 0.2M Na-K Tartrate, 0.1M MES pH6.5
|
Resolution 2.80 Å
|
|
6U3O
JR51 DQ2-p.aeru-alpha2a complex
Deposited 2019-08-22
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain F
1–192(192 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;23%PEG3350, 0.01mM Na-Acetate, 0.1 M Tris pH8.0
|
Resolution 2.74 Å
|
|
6U3O
JR51 DQ2-p.aeru-alpha2a complex
Deposited 2019-08-22
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
1–192(192 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;23%PEG3350, 0.01mM Na-Acetate, 0.1 M Tris pH8.0
|
Resolution 2.74 Å
|
|
7SG0
W316 TCR in complex with HLA-DQ2-omega1
Deposited 2021-10-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
EDO 1,2-ETHANEDIOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;24% PEG3350, 0.25 M (NH4)2SO4 and 0.1 M Tris/HCl at pH 8.0
|
Resolution 3.00 Å
R-free 0.230
|
|
7SG1
XPA5 TCR in complex with HLA-DQ2-alpha1
Deposited 2021-10-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
EDO 1,2-ETHANEDIOL × 1
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;Mother liquor: 16-18% PEG3350, 0.12-0.14 M CaOAc, 0.1 M Tris/HCl at pH 8.0, Additives: 2 mM reduced and oxidised Glutathione
|
Resolution 3.10 Å
R-free 0.258
|
|
7SG1
XPA5 TCR in complex with HLA-DQ2-alpha1
Deposited 2021-10-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain G
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;Mother liquor: 16-18% PEG3350, 0.12-0.14 M CaOAc, 0.1 M Tris/HCl at pH 8.0, Additives: 2 mM reduced and oxidised Glutathione
|
Resolution 3.10 Å
R-free 0.258
|
|
7SG2
XPA5 TCR in complex with HLA-DQ2-omega1
Deposited 2021-10-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
EDO 1,2-ETHANEDIOL × 1
ACT ACETATE ION × 1
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;Mother liquor: 16-18% PEG3350, 0.12-0.14 M CaOAc, 0.1 M Tris/HCl at pH 8.0, Additives: 2 mM reduced and oxidised Glutathione
|
Resolution 3.10 Å
R-free 0.259
|
|
7SG2
XPA5 TCR in complex with HLA-DQ2-omega1
Deposited 2021-10-04
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain G
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
EDO 1,2-ETHANEDIOL × 2
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;Mother liquor: 16-18% PEG3350, 0.12-0.14 M CaOAc, 0.1 M Tris/HCl at pH 8.0, Additives: 2 mM reduced and oxidised Glutathione
|
Resolution 3.10 Å
R-free 0.259
|
|
8W83
HLA-DQ2.5-alpha1 gliadin peptide in complex with DQN0344AE02
Deposited 2023-08-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain D
1–190(190 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;294 K;0.1 M HEPES (pH7.5), 25.0 %w/v Polyethylene glycol 1,000, and 20 %v/v Glycerol as cryoprotectant
|
Resolution 2.82 Å
R-free 0.321
|
|
8W83
HLA-DQ2.5-alpha1 gliadin peptide in complex with DQN0344AE02
Deposited 2023-08-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain H
1–190(190 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;294 K;0.1 M HEPES (pH7.5), 25.0 %w/v Polyethylene glycol 1,000, and 20 %v/v Glycerol as cryoprotectant
|
Resolution 2.82 Å
R-free 0.321
|
|
8W83
HLA-DQ2.5-alpha1 gliadin peptide in complex with DQN0344AE02
Deposited 2023-08-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain L
1–190(190 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;294 K;0.1 M HEPES (pH7.5), 25.0 %w/v Polyethylene glycol 1,000, and 20 %v/v Glycerol as cryoprotectant
|
Resolution 2.82 Å
R-free 0.321
|
|
8W83
HLA-DQ2.5-alpha1 gliadin peptide in complex with DQN0344AE02
Deposited 2023-08-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain P
1–190(190 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;294 K;0.1 M HEPES (pH7.5), 25.0 %w/v Polyethylene glycol 1,000, and 20 %v/v Glycerol as cryoprotectant
|
Resolution 2.82 Å
R-free 0.321
|
|
8W84
HLA-DQ2.5-alpha2 gliadin peptide in complex with DQN0344AE02
Deposited 2023-08-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain D
1–190(190 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;80 mM di-Sodium malonate (pH4.0), 9.6 %w/v Polyethylene glycol 3,350, and 25 %v/v Ethylene glycol as cryoprotectant
|
Resolution 2.10 Å
R-free 0.325
|
|
8W85
HLA-DQ2.5-gamma2 gliadin peptide in complex with DQN0385AE01
Deposited 2023-08-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain D
1–190(190 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;0.1 M Ammonium sulfate,
10.0 %w/v Polyethylene glycol 3,350, and 30 %v/v Ethylene glycol as cryoprotectant
|
Resolution 2.77 Å
R-free 0.300
|
|
8W85
HLA-DQ2.5-gamma2 gliadin peptide in complex with DQN0385AE01
Deposited 2023-08-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain H
1–190(190 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;0.1 M Ammonium sulfate,
10.0 %w/v Polyethylene glycol 3,350, and 30 %v/v Ethylene glycol as cryoprotectant
|
Resolution 2.77 Å
R-free 0.300
|
|
8W86
HLA-DQ2.5-B/C hordein peptide in complex with DQN0385AE02
Deposited 2023-08-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain D
1–190(190 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;294 K;0.1 M MES monohydrate (pH5.5), 12.0 %w/v Polyethylene glycol 8,000, 0.1 M Calcium acetate hydrate, and 30 %v/v Ethylene glycol as cryoprotectant
|
Resolution 2.24 Å
R-free 0.280
|
|
8W86
HLA-DQ2.5-B/C hordein peptide in complex with DQN0385AE02
Deposited 2023-08-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain H
1–190(190 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;294 K;0.1 M MES monohydrate (pH5.5), 12.0 %w/v Polyethylene glycol 8,000, 0.1 M Calcium acetate hydrate, and 30 %v/v Ethylene glycol as cryoprotectant
|
Resolution 2.24 Å
R-free 0.280
|
|
9EJG
Peptide-independent T cell receptor recognition of HLA-DQ2
Deposited 2024-11-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–194(194 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
FMT FORMIC ACID × 5
GOL GLYCEROL × 2
ACT ACETATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;8% Tacsimate, pH 8.0, 20-24% w/v PEG3350
|
Resolution 2.20 Å
R-free 0.225
|
|
9EJH
Peptide-independent T cell receptor recognition of HLA-DQ2
Deposited 2024-11-27
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
ACT ACETATE ION × 4
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;8% Tacsimate, pH 8.0, 20-24% w/v PEG3350
|
Resolution 2.45 Å
R-free 0.232
|